These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11245036)

  • 21. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
    Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
    Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear bodies in Creutzfeldt-Jakob and Alzheimer's diseases.
    Grunnet ML
    Neurology; 1975 Nov; 25(11):1091-3. PubMed ID: 171599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progressive myoclonic cerebellar ataxia as a manifestation of Creutzfeldt-Jakob disease].
    Santos S; Pascual-Millán LF; Escalza-Codina I; Navas-Vinagre I; López del Val LJ; Mostacero-Miguel E; Ramón y Cajal S
    Rev Neurol; 2003 Sep 16-30; 37(6):535-8. PubMed ID: 14533072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease.
    Prasad S; Ko MW; Lee EB; Gonatas NK; Stern MB; Galetta S
    J Neurol Sci; 2007 Feb; 253(1-2):69-72. PubMed ID: 17234215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
    Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alien hand syndrome in Creutzfeldt-Jakob disease].
    Colomer Rubio E; Sánchez Roy R; Pareja Martínez A; Perla C; Villarroya T; Cerdá Nicolás M; Carbonell C
    Neurologia; 2001 May; 16(5):223-6. PubMed ID: 11412722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinico-pathological study of a case of Jakob-Creutzfeldt and narcoleptic syndrome (author's transl)].
    Galatioto S; Di Perri R
    Riv Patol Nerv Ment; 1974 Oct; 95(5):512-24. PubMed ID: 4620180
    [No Abstract]   [Full Text] [Related]  

  • 29. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
    Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
    Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease.
    Hellmann MA; Melamed E
    Mov Disord; 2002 Sep; 17(5):1097-8. PubMed ID: 12360570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurodegenerative causes of myoclonus.
    Thompson PD
    Adv Neurol; 2002; 89():31-4. PubMed ID: 11968458
    [No Abstract]   [Full Text] [Related]  

  • 32. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
    Tabaton M; Monaco S; Cordone MP; Colucci M; Giaccone G; Tagliavini F; Zanusso G
    Ann Neurol; 2004 Feb; 55(2):294-6. PubMed ID: 14755736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coexistence of motor neuron disease with dementia and Alzheimer's disease].
    Yamashita M; Yamamoto T
    Rinsho Shinkeigaku; 2002 Aug; 42(8):771; discussion 772. PubMed ID: 12701226
    [No Abstract]   [Full Text] [Related]  

  • 34. Unilateral positive-negative myoclonus in Creutzfeldt-Jakob disease.
    Ohnari K; Matsunaga K; Uozumi T; Tamagawa A; Hashimoto T; Tsuji S
    Mov Disord; 2006 Nov; 21(11):1963-6. PubMed ID: 16960864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.
    Silveyra MX; Cuadrado-Corrales N; Marcos A; Barquero MS; Rábano A; Calero M; Sáez-Valero J
    J Neurochem; 2006 Jan; 96(1):97-104. PubMed ID: 16277609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease presenting as progressive aphasia.
    Shuttleworth EC; Yates AJ; Paltan-Ortiz JD
    J Natl Med Assoc; 1985 Aug; 77(8):649-50, 652, 655-6. PubMed ID: 3900429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Creutzfeldt-Jakob disease presenting with nonconvulsive status epilepticus.
    Cohen D; Kutluay E; Edwards J; Peltier A; Beydoun A
    Epilepsy Behav; 2004 Oct; 5(5):792-6. PubMed ID: 15380138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of myoclonus.
    Caviness JN
    Adv Neurol; 2002; 89():19-22. PubMed ID: 11968444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hearing loss as the initial presentation of Creutzfeldt-Jakob disease.
    Krishna P; Bauer C
    Ear Nose Throat J; 2004 Aug; 83(8):535, 538, 540 passim. PubMed ID: 15487633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central nervous system amyloidoses: a comparison of Alzheimer's disease and Creutzfeldt-Jakob disease.
    Brown P
    Neurology; 1989 Aug; 39(8):1103-5. PubMed ID: 2668786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.